Related Experiment Video
Updated: Dec 30, 2025

09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
4.1K
Incretins and microRNAs: Interactions and physiological relevance
Shabnam Radbakhsh1, Thozhukat Sathyapalan2, Maciej Banach3
1Department of Medical Biotechnology, Mashhad University of Medical Sciences, Mashhad, Iran.
Pharmacological Research
|January 27, 2020
Summary
MicroRNAs (miRNAs) influence incretin hormones like GLP-1 and GIP, impacting glucose control. This review explores how miRNAs interact with incretins and DPP-4 inhibitors, relevant to type 2 diabetes.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small regulatory RNAs affecting gene expression.
- Incretin hormones (GLP-1, GLP-2, GIP) are vital for glucose homeostasis and beta-cell function.
- Glucagon-like peptide-1 receptor agonists (GLP1RA) and DPP-4 inhibitors are used in type 2 diabetes management.
Purpose of the Study:
- To review the interactions between miRNAs and incretin hormones.
- To elucidate the relevance of these interactions in physiological processes and diseases, particularly type 2 diabetes.
Main Methods:
- Literature review of studies investigating miRNA and incretin hormone interactions.
- Analysis of how GLP1RA and DPP-4 inhibitors affect miRNA expression.
- Synthesis of current knowledge on the physiological and pathological implications.
Main Results:
- miRNAs can modulate the expression of incretin hormones and their receptors.
- GLP1RA and DPP-4 inhibitors can alter miRNA expression profiles.
- These interactions suggest a complex regulatory network influencing glucose metabolism.
Conclusions:
- miRNA-incretin axis represents a significant area for understanding glucose homeostasis.
- Targeting this axis may offer novel therapeutic strategies for type 2 diabetes.
- Further research is needed to fully delineate these complex molecular interactions.
Related Concept Videos
Glucagon-like Receptor Agonists
767
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
767
MicroRNAs
3.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Hormones Regulating Blood Glucose
6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K
Microvilli
8.7K
Microvilli are tiny finger-like projections found on the surface of certain cells. Their purpose is to increase the surface area of the cell's apical surface, resulting in more effective absorption or secretion of substances.
These microvilli are predominantly present in cells lining the small intestine, kidney tubules, and certain cells in the respiratory and reproductive systems. By significantly expanding the surface area of the cell membrane, microvilli enhance the cell's capacity...
These microvilli are predominantly present in cells lining the small intestine, kidney tubules, and certain cells in the respiratory and reproductive systems. By significantly expanding the surface area of the cell membrane, microvilli enhance the cell's capacity...
8.7K

